Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2011 Jun;43(6):297-304.
doi: 10.1016/j.aprim.2010.05.016. Epub 2011 Jan 14.

[Evaluation and control of hypertensive diabetics seen in Primary Care centres in Spain. BRAND II study]

[Article in Spanish]
Affiliations
Multicenter Study

[Evaluation and control of hypertensive diabetics seen in Primary Care centres in Spain. BRAND II study]

[Article in Spanish]
José Abellán Alemán et al. Aten Primaria. 2011 Jun.

Abstract

Objective: We aimed to verify the level of blood pressure and glucose control and treatment in hypertensive diabetics seen in Primary Care Centres in Spain.

Design: Descriptive study conducted on hypertensive diabetic patients who attended primary care centres for any reason.

Location: Primary Care centres throughout Spain.

Participants: The study included 6,777 patients.

Measurements: Blood pressure, weight, height, waist circumference, blood analysis and treatment were recorded

Results: The mean age of the sample was 64.40 (11.50) years. Mean blood glucose was 141.8 (39) mg/dl, glycosylated haemoglobin was ≤7% in 45.9% of the sample, and blood pressure was under control (BP≤130/80 mmHg) in 9.8% of the patients studied. LDL Cholesterol was ≤100mg/dl in 25.3% of the sample. The drugs most used to control diabetes were; sulphonylureas 2259 patients (33.3%) and biguanides 3768 patients (55.6%). A total of 556 patients were on treatment with insulin, which represented 8.2% of the population studied. The drugs most used for hypertension were; diuretics in 3395 patients (50.1%) and angiotensin-converting enzyme inhibitors in 4053 patients (59.8%).

Conclusions: A large proportion of hypertensive diabetics are insufficiently controlled.

Objetivo: Estudiar el grado de control y el tratamiento empleado en los hipertensos diabéticos atendidos en los centros de Atención Primaria en España.

Diseño: Estudio descriptivo realizado a pacientes hipertensos y diabéticos que acuden a consulta médica de Atención Primaria por cualquier motivo.

Emplazamiento: Centros de Atención Primaria de todo el territorio nacional.

Participantes: Se incluyeron 6.777 pacientes.

Mediciones principales: Se les determinó la presión arterial, peso, talla, perímetro de cintura, analítica completa y tratamiento.

Resultados: La edad media de la muestra fue de 64,40 ± 11,50 años. La glucosa media fue de 141,8 ± 39 mg/dl, la hemoglobina glicosilada fue < 7% en el 45,9% de la muestra y la presión arterial estaba controlada (PA < 130/80 mmHg) en el 9,8% de los pacientes estudiados. El LDL colesterol era inferior a 100 mg/dl en el 25,3% de los pacientes. Los fármacos más utilizados para el control de la diabetes fueron las sulfonilureas en 2.259 pacientes (33,1%) y las biguanidas en 3.768 pacientes (55,6%). Estaban en tratamiento con insulina 556 pacientes, lo que representa el 8,2%. Respecto a la hipertensión arterial los fármacos más utilizados fueron los diuréticos en 3.395 pacientes (50,1%) y los inhibidores de la enzima convertidora de angiotensina en 4.053 pacientes (59,8%).

Conclusiones: Gran parte de los hipertensos diabéticos están insuficientemente controlados.

PubMed Disclaimer

Figures

None
Esquema general del estudio. Evaluación y control en hipertensos diabéticos. BRAND II.
Figura 1
Figura 1
Proporción de pacientes controlados en los diferentes parámetros.

Similar articles

Cited by

References

    1. Arauz-Pacheco C., Parrot M.A., Raskin P. The treatment of hypertension in adult patients with diabetes. Diabetes Care. 2002;25:134–147. - PubMed
    1. Parving H.H. Controlling hypertension in diabetes. Acta Diabetol. 2002;39(Suppl 2):S35–S40. - PubMed
    1. Rodríguez A., Banegas J., de Andrés B., del Rey J. Principios de prevención cardiovascular. Med Clin (Barc). 1999;112:459–464. - PubMed
    1. Julius S., Majahalme S., Palatini P. Antihypertensive treatment of patients with diabetes and hypertension. Am J Hypertens. 2001;14:310S–316S. - PubMed
    1. UKPDS Group: High Blood Pressure control and risk of macrovascular and microvascular manifestations in type 2 Diabetes (UKPDS 38). BMJ. 1998;317:201–72. - PMC - PubMed